Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7 CYP2A13	3.09e-07	3	136	3	GO:0008389
GeneOntologyMolecularFunction	ethanol binding	ADH1A ADH1B ADH1C	6.09e-06	6	136	3	GO:0035276
GeneOntologyBiologicalProcess	acetaldehyde biosynthetic process	ADH1A ADH1B ADH1C	2.80e-07	3	136	3	GO:0046186
GeneOntologyBiologicalProcess	aldehyde biosynthetic process	MDH2 ADH1A ADH1B ADH1C SLC25A10	1.71e-06	31	136	5	GO:0046184
GeneOntologyBiologicalProcess	acetaldehyde metabolic process	ADH1A ADH1B ADH1C	2.78e-06	5	136	3	GO:0006117
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	CYP2A6 CYP2A7 CYP2A13	3.25e-05	10	136	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	CYP2A6 CYP2A7 CYP2A13	3.25e-05	10	136	3	GO:0009804
GeneOntologyBiologicalProcess	xenobiotic metabolic process	ABCC3 CYP2A6 CYP2A7 CYP2A13 SLCO2B1 UGT1A1 NOS1	4.21e-05	141	136	7	GO:0006805
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	ABCC3 CYP2A6 CYP2A7 CYP2A13 ABCA1 SLCO2B1 UGT1A1 NOS1	1.15e-04	222	136	8	GO:0071466
GeneOntologyBiologicalProcess	retinoic acid metabolic process	ADH1A ADH1B ADH1C UGT1A1	1.37e-04	40	136	4	GO:0042573
GeneOntologyBiologicalProcess	behavioral response to ethanol	ADH1A ADH1B ADH1C	1.78e-04	17	136	3	GO:0048149
GeneOntologyBiologicalProcess	ethanol catabolic process	ADH1A ADH1B ADH1C	1.78e-04	17	136	3	GO:0006068
GeneOntologyBiologicalProcess	ethanol metabolic process	ADH1A ADH1B ADH1C	2.13e-04	18	136	3	GO:0006067
GeneOntologyBiologicalProcess	cortical actin cytoskeleton organization	CORO1C STRIP1 LLGL2 FHOD1	2.18e-04	45	136	4	GO:0030866
MousePheno	decreased intestinal cholesterol absorption	CYP2A6 CYP2A7 CYP2A13 ABCA1	6.89e-06	17	106	4	MP:0002647
MousePheno	abnormal ethanol metabolism	ADH1A ADH1B ADH1C	8.34e-06	6	106	3	MP:0005443
MousePheno	abnormal intestinal cholesterol absorption	CYP2A6 CYP2A7 CYP2A13 ABCA1	1.11e-05	19	106	4	MP:0002645
MousePheno	abnormal retinol metabolism	ADH1A ADH1B ADH1C	1.45e-05	7	106	3	MP:0005444
MousePheno	abnormal xenobiotic pharmacokinetics	ABCC3 CYP2A6 CYP2A13 SLCO2B1	7.35e-05	30	106	4	MP:0008875
MousePheno	abnormal intestinal lipid absorption	CYP2A6 CYP2A7 CYP2A13 ABCA1	8.39e-05	31	106	4	MP:0005342
MousePheno	abnormal vitamin metabolism	ADH1A ADH1B ADH1C	1.80e-04	15	106	3	MP:0013244
MousePheno	abnormal vitamin or vitamin cofactor metabolism	ADH1A ADH1B ADH1C	1.80e-04	15	106	3	MP:0013274
MousePheno	abnormal vitamin A metabolism	ADH1A ADH1B ADH1C	1.80e-04	15	106	3	MP:0011233
MousePheno	enhanced behavioral response to alcohol	ADH1A ADH1B ADH1C	2.21e-04	16	106	3	MP:0009751
MousePheno	abnormal susceptibility to induced morbidity/mortality	CERK PARP2 ADGRV1 STRIP2 ADH1A ADH1B ADH1C C4A C4B PLCL1 NOS1 DDX39B	2.32e-04	471	106	12	MP:0020148
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7 CYP2A13	1.47e-06	4	135	3	IPR008067
Domain	ADH_Zn_CS	ADH1A ADH1B ADH1C	2.01e-05	8	135	3	IPR002328
Domain	ADH_ZINC	ADH1A ADH1B ADH1C	2.01e-05	8	135	3	PS00059
Domain	-	ASF1B ASF1A	5.19e-05	2	135	2	2.60.40.1490
Domain	ASF1_hist_chap	ASF1B ASF1A	5.19e-05	2	135	2	PF04729
Domain	DUF3402	STRIP2 STRIP1	5.19e-05	2	135	2	SM01293
Domain	N1221	STRIP2 STRIP1	5.19e-05	2	135	2	SM01292
Domain	DUF3402	STRIP2 STRIP1	5.19e-05	2	135	2	PF11882
Domain	N1221	STRIP2 STRIP1	5.19e-05	2	135	2	PF07923
Domain	DUF3402	STRIP2 STRIP1	5.19e-05	2	135	2	IPR021819
Domain	N1221	STRIP2 STRIP1	5.19e-05	2	135	2	IPR012486
Domain	ASF1-like	ASF1B ASF1A	5.19e-05	2	135	2	IPR006818
Domain	PKS_ER	ADH1A ADH1B ADH1C	1.93e-04	16	135	3	IPR020843
Domain	ADH_N	ADH1A ADH1B ADH1C	1.93e-04	16	135	3	PF08240
Domain	PKS_ER	ADH1A ADH1B ADH1C	1.93e-04	16	135	3	SM00829
Domain	ADH_N	ADH1A ADH1B ADH1C	1.93e-04	16	135	3	IPR013154
Domain	-	ADH1A ADH1B ADH1C	2.78e-04	18	135	3	3.90.180.10
Domain	ADH_zinc_N	ADH1A ADH1B ADH1C	3.29e-04	19	135	3	PF00107
Domain	ADH_SF_Zn-type	ADH1A ADH1B ADH1C	3.29e-04	19	135	3	IPR002085
Domain	ADH_C	ADH1A ADH1B ADH1C	3.29e-04	19	135	3	IPR013149
Domain	Anaphylatoxin_comp_syst	C4A C4B	5.11e-04	5	135	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	5.11e-04	5	135	2	IPR001840
Domain	GroES-like	ADH1A ADH1B ADH1C	6.69e-04	24	135	3	IPR011032
Domain	BRK	CHD8 CHD6	7.63e-04	6	135	2	SM00592
Domain	HNOB_dom_associated	GUCY1B2 GUCY2F	7.63e-04	6	135	2	IPR011645
Domain	BRK_domain	CHD8 CHD6	7.63e-04	6	135	2	IPR006576
Domain	HNOBA	GUCY1B2 GUCY2F	7.63e-04	6	135	2	PF07701
Domain	BRK	CHD8 CHD6	7.63e-04	6	135	2	PF07533
Domain	ANATO	C4A C4B	1.06e-03	7	135	2	SM00104
Domain	ANAPHYLATOXIN_2	C4A C4B	1.06e-03	7	135	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	1.06e-03	7	135	2	PS01177
Domain	ANATO	C4A C4B	1.06e-03	7	135	2	PF01821
Domain	Anaphylatoxin/fibulin	C4A C4B	1.06e-03	7	135	2	IPR000020
Domain	Helicase_C	CHD8 DDX6 CHD6 DDX39A DDX39B	1.08e-03	107	135	5	PF00271
Domain	HELICc	CHD8 DDX6 CHD6 DDX39A DDX39B	1.08e-03	107	135	5	SM00490
Domain	Helicase_C	CHD8 DDX6 CHD6 DDX39A DDX39B	1.13e-03	108	135	5	IPR001650
Domain	HELICASE_CTER	CHD8 DDX6 CHD6 DDX39A DDX39B	1.17e-03	109	135	5	PS51194
Domain	HELICASE_ATP_BIND_1	CHD8 DDX6 CHD6 DDX39A DDX39B	1.17e-03	109	135	5	PS51192
Domain	DEXDc	CHD8 DDX6 CHD6 DDX39A DDX39B	1.17e-03	109	135	5	SM00487
Domain	Helicase_ATP-bd	CHD8 DDX6 CHD6 DDX39A DDX39B	1.22e-03	110	135	5	IPR014001
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	1.41e-03	8	135	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	1.41e-03	8	135	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	1.41e-03	8	135	2	IPR019742
Domain	FHA	FOXK2 KIF1B APTX	1.43e-03	31	135	3	PF00498
Domain	-	FOXK2 KIF1B APTX	2.21e-03	36	135	3	2.60.200.20
Domain	FHA_dom	FOXK2 KIF1B APTX	2.21e-03	36	135	3	IPR000253
Domain	A2M	C4A C4B	2.25e-03	10	135	2	PF00207
Domain	A2M_N_2	C4A C4B	2.25e-03	10	135	2	IPR011625
Domain	A2M_comp	C4A C4B	2.25e-03	10	135	2	IPR011626
Domain	A2M_recep	C4A C4B	2.25e-03	10	135	2	PF07677
Domain	A2M_comp	C4A C4B	2.25e-03	10	135	2	PF07678
Domain	A2M_N	C4A C4B	2.25e-03	10	135	2	PF01835
Domain	A2M_N	C4A C4B	2.25e-03	10	135	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B	2.25e-03	10	135	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B	2.25e-03	10	135	2	PS00477
Domain	A2M_N_2	C4A C4B	2.25e-03	10	135	2	PF07703
Domain	Macroglobln_a2	C4A C4B	2.25e-03	10	135	2	IPR001599
Domain	Q_MOTIF	DDX6 DDX39A DDX39B	2.40e-03	37	135	3	PS51195
Domain	RNA_helicase_DEAD_Q_motif	DDX6 DDX39A DDX39B	2.40e-03	37	135	3	IPR014014
Domain	Cyt_P450_E_grp-I	CYP2A6 CYP2A7 CYP2A13	4.20e-03	45	135	3	IPR002401
Domain	HEAT	NCAPG2 NCAPG UTP20	5.04e-03	48	135	3	PF02985
Domain	-	ARID3A JARID2	5.12e-03	15	135	2	1.10.150.60
Domain	BRIGHT	ARID3A JARID2	5.12e-03	15	135	2	SM00501
Domain	ARID_dom	ARID3A JARID2	5.12e-03	15	135	2	IPR001606
Domain	ARID	ARID3A JARID2	5.12e-03	15	135	2	PS51011
Domain	ARID	ARID3A JARID2	5.12e-03	15	135	2	PF01388
Domain	EGF_CA	FAT1 HMCN2 VCAN LRP5	5.79e-03	99	135	4	PS01187
Domain	SMAD_FHA_domain	FOXK2 KIF1B APTX	6.30e-03	52	135	3	IPR008984
Domain	HSP70_2	HSPA12B HSPA8	6.57e-03	17	135	2	PS00329
Domain	HSP70_1	HSPA12B HSPA8	6.57e-03	17	135	2	PS00297
Domain	C345C	C4A C4B	6.57e-03	17	135	2	SM00643
Domain	HSP70_3	HSPA12B HSPA8	6.57e-03	17	135	2	PS01036
Domain	Cyt_P450_CS	CYP2A6 CYP2A7 CYP2A13	6.65e-03	53	135	3	IPR017972
Pathway	KEGG_RETINOL_METABOLISM	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C UGT1A1	3.26e-07	64	100	7	M9488
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C UGT1A1	7.39e-07	72	100	7	M9257
Pathway	WP_FATTY_ACID_OMEGAOXIDATION	CYP2A6 ADH1A ADH1B ADH1C	3.06e-06	15	100	4	M39717
Pathway	REACTOME_ABACAVIR_ADME	ADH1A ADH1B ADH1C	1.89e-05	8	100	3	MM14869
Pathway	REACTOME_DRUG_ADME	ABCC3 SLCO2B1 ADH1A ADH1B ADH1C GGT5 UGT1A1	2.14e-05	119	100	7	MM15692
Pathway	WP_FATTY_ACID_OMEGAOXIDATION	ADH1A ADH1B ADH1C	4.01e-05	10	100	3	MM15833
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13	5.48e-05	11	100	3	M27130
Pathway	REACTOME_ETHANOL_OXIDATION	ADH1A ADH1B ADH1C	5.48e-05	11	100	3	MM15405
Pathway	REACTOME_ETHANOL_OXIDATION	ADH1A ADH1B ADH1C	7.27e-05	12	100	3	M14663
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13	7.27e-05	12	100	3	MM14847
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C	9.49e-05	104	100	6	M738
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C	1.00e-04	105	100	6	MM14842
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C GGT5 UGT1A1	1.63e-04	219	100	8	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C GGT5 UGT1A1	1.68e-04	220	100	8	M10320
Pathway	REACTOME_FATTY_ACIDS	CYP2A6 CYP2A7 CYP2A13	2.62e-04	18	100	3	MM14841
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	CYP2A6 CYP2A7 CYP2A13 UGT1A1	4.61e-04	51	100	4	M17726
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS	CYP2A6 CYP2A13	4.91e-04	5	100	2	M47808
Pathway	REACTOME_XENOBIOTICS	CYP2A6 CYP2A7 CYP2A13	5.53e-04	23	100	3	M5372
Pathway	REACTOME_XENOBIOTICS	CYP2A6 CYP2A7 CYP2A13	7.11e-04	25	100	3	MM14846
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	31645370
Pubmed	Retinol/ethanol drug interaction during acute alcohol intoxication in mice involves inhibition of retinol metabolism to retinoic acid by alcohol dehydrogenase.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	11960985
Pubmed	Tissue-specific genetic variation in the level of mouse alcohol dehydrogenase is controlled transcriptionally in kidney and posttranscriptionally in liver.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	2474823
Pubmed	Chromosomal assignment of the alcohol dehydrogenase cluster locus to human chromosome 4q21-23 by in situ hybridization.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	2737681
Pubmed	Regulation of human class I alcohol dehydrogenases by bile acids.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	23772048
Pubmed	A negative regulatory element upstream from the mouse Adh-1 gene can down-regulate a heterologous promoter.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	8163197
Pubmed	ALDH expression characterizes G1-phase proliferating beta cells during pregnancy.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	24787690
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	8188299
Pubmed	Androgen induction of alcohol dehydrogenase in mouse kidney. Studies with a cDNA probe confirmed by nucleotide sequence analysis.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	3011597
Pubmed	Alcohol dehydrogenase isozymes in the mouse: genetic regulation, allelic variation among inbred strains and sex differences of liver and kidney A2 isozyme activity.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	6756216
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	8250953
Pubmed	CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk.	CYP2A13 ADH1B ADH1C	6.38e-08	3	140	3	19812523
Pubmed	Alcohol dehydrogenase 1 is a tubular mitophagy-dependent apoptosis inhibitor against septic acute kidney injury.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	37806378
Pubmed	Structure and function of a long alternating purine-pyrimidine sequence in the mouse alcohol dehydrogenase Adh-1 gene.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	7840644
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	2703500
Pubmed	Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	15670660
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	22217847
Pubmed	Stage and tissue-specific expression of the alcohol dehydrogenase 1 (Adh-1) gene during mouse development.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	8018987
Pubmed	Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	33586683
Pubmed	Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	22890016
Pubmed	Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	3157987
Pubmed	Promoters for the human alcohol dehydrogenase genes ADH1, ADH2, and ADH3: interaction of CCAAT/enhancer-binding protein with elements flanking the ADH2 TATA box.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	2169444
Pubmed	Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients.	ADH1B ADH1C UGT1A1	6.38e-08	3	140	3	24217933
Pubmed	A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	8486690
Pubmed	Individual susceptibility and alcohol effects:biochemical and genetic aspects.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	16801720
Pubmed	Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	10424757
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	3346244
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	2733794
Pubmed	The human class I alcohol dehydrogenase gene cluster: three genes are tandemly organized in an 80-kb-long segment of the genome.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	2347582
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	8484736
Pubmed	Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	17326332
Pubmed	The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	7748347
Pubmed	Genetics of human alcohol and aldehyde dehydrogenases.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	3006456
Pubmed	Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	9145544
Pubmed	Structure of the mouse Adh-1 gene and identification of a deletion in a long alternating purine-pyrimidine sequence in the first intron of strains expressing low alcohol dehydrogenase activity.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	3428612
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	1417950
Pubmed	Genetic and developmental regulation of mouse liver alcohol dehydrogenase.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	6816803
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	24045421
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	32987105
Pubmed	Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	2765478
Pubmed	Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.	CYP2A6 CYP2A7 CYP2A13	6.38e-08	3	140	3	2415518
Pubmed	Ten kilobases of 5'-flanking region confers proper regulation of the mouse alcohol dehydrogenase-1 (Adh-1) gene in kidney and adrenal of transgenic mice.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	8973327
Pubmed	The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	15554233
Pubmed	ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	35354963
Pubmed	Purification and characterization of mouse alcohol dehydrogenase from two inbred strains that differ in total liver enzyme activity.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	6370228
Pubmed	Three human alcohol dehydrogenase subunits: cDNA structure and molecular and evolutionary divergence.	ADH1A ADH1B ADH1C	6.38e-08	3	140	3	2935875
Pubmed	Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects.	ABCC3 CYP2A6 CYP2A13 ABCA1 SLCO2B1 ADH1A ADH1B ADH1C UGT1A1	9.70e-08	193	140	9	19343046
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	FOXK2 ORC3 CORO1C PARP2 APTX DYRK1A CHD8 STRIP1 DDX6 LGALS8 MEST JARID2 SPCS3 SLC9A1 ZC3H11A UBXN4 WDR75 IMP4 SLC25A10 UTP20 CHD6 ASF1A	1.49e-07	1497	140	22	31527615
Pubmed	Ontogeny of rdh9 (Crad3) expression: ablation causes changes in retinoid and steroid metabolizing enzymes, but RXR and androgen signaling seem normal.	CYP2A6 CYP2A13 ADH1A ADH1B ADH1C	1.81e-07	32	140	5	17270348
Pubmed	Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.	CYP2A6 CYP2A7 CYP2A13	2.55e-07	4	140	3	10490589
Pubmed	Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.	CYP2A6 CYP2A7 CYP2A13	2.55e-07	4	140	3	1970547
Pubmed	Genetic regulation of gene-specific mRNA by ethanol in vivo and its possible role in ethanol preference in a cross with RI lines in mice.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	8813054
Pubmed	Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	12631290
Pubmed	Molecular analysis of mouse alcohol dehydrogenase: nucleotide sequence of the Adh-1 gene and genetic mapping of a related nucleotide sequence to chromosome 3.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	2893758
Pubmed	Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	11893554
Pubmed	Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.	CYP2A6 CYP2A7 CYP2A13	2.55e-07	4	140	3	9408084
Pubmed	Metabolic pharmacokinetics of early chronic alcohol consumption mediated by liver alcohol dehydrogenases 1 and 3 in mice.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	29663519
Pubmed	Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	12851412
Pubmed	ADH1 and ADH4 alcohol/retinol dehydrogenases in the developing adrenal blastema provide evidence for embryonic retinoid endocrine function.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	9733106
Pubmed	Hepatic CYP2B10 is highly induced by binge ethanol and contributes to acute-on-chronic alcohol-induced liver injury.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	36224745
Pubmed	Retinoic acid and alcohol/retinol dehydrogenase in the mouse adrenal gland: a potential endocrine source of retinoic acid during development.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	9202249
Pubmed	Effects of polymorphisms in untranslated regions of the class I alcohol dehydrogenase (ADH) genes on alcohol metabolism in Japanese subjects and transcriptional activity in HepG2 cells.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	19618839
Pubmed	Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	3996732
Pubmed	A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.	CYP2A6 CYP2A7 CYP2A13	2.55e-07	4	140	3	7565685
Pubmed	Genetic mapping of a possible new alcohol dehydrogenase sequence to mouse chromosome 3 at the Adh-1/Adh-3 complex.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	9241435
Pubmed	Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	10880953
Pubmed	Localization of class I and class IV alcohol dehydrogenases in mouse testis and epididymis: potential retinol dehydrogenases for endogenous retinoic acid synthesis.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	9002638
Pubmed	Opposing actions of cellular retinol-binding protein and alcohol dehydrogenase control the balance between retinol storage and degradation.	ADH1A ADH1B ADH1C	2.55e-07	4	140	3	15193143
Pubmed	Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	11836246
Pubmed	Retinoic acid synthesis in mouse embryos during gastrulation and craniofacial development linked to class IV alcohol dehydrogenase gene expression.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	8621625
Pubmed	Assignment of the rat genes coding for alpha 1-antitrypsin (PI), phosphoenolpyruvate carboxykinase (PEPCK), alcohol dehydrogenase (ADH), and fructose-1,6-bisphosphatase (FDP).	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	1316195
Pubmed	Cloning of the mouse class IV alcohol dehydrogenase (retinol dehydrogenase) cDNA and tissue-specific expression patterns of the murine ADH gene family.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	7738026
Pubmed	Expression patterns of class I and class IV alcohol dehydrogenase genes in developing epithelia suggest a role for alcohol dehydrogenase in local retinoic acid synthesis.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	8892527
Pubmed	Mouse alcohol dehydrogenase isozymes: products of closely localized duplicate genes exhibiting divergent kinetic properties.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	7026729
Pubmed	ADH single nucleotide polymorphism associations with alcohol metabolism in vivo.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	19193628
Pubmed	Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	22079585
Pubmed	Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid.	ADH1A ADH1B ADH1C	6.35e-07	5	140	3	10358022
Pubmed	High and complementary expression patterns of alcohol and aldehyde dehydrogenases in the gastrointestinal tract: implications for Parkinson's disease.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	17257171
Pubmed	A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.	CYP2A6 CYP2A7 CYP2A13	1.27e-06	6	140	3	7668294
Pubmed	Alcohol Dehydrogenase Protects against Endoplasmic Reticulum Stress-Induced Myocardial Contractile Dysfunction via Attenuation of Oxidative Stress and Autophagy: Role of PTEN-Akt-mTOR Signaling.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	26807981
Pubmed	Excessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	12027900
Pubmed	Merging protein, gene and genomic data: the evolution of the MDR-ADH family.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	16121213
Pubmed	Human liver alcohol dehydrogenase: purification, composition, and catalytic features.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	9982
Pubmed	Genetics and ontogeny of alcohol dehydrogenase isozymes in the mouse: evidence for a cis-acting regulator gene (Adt-i) controlling C2 isozyme expression in reproductive tissues and close linkage of Adh-3 and Adt-i on chromosome 3.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	518534
Pubmed	Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans.	ADH1A ADH1B ADH1C	1.27e-06	6	140	3	17185388
Pubmed	Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.	CYP2A6 CYP2A7 CYP2A13	1.27e-06	6	140	3	8587134
Pubmed	Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	16685648
Pubmed	Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.	CYP2A6 CYP2A7 CYP2A13	2.21e-06	7	140	3	9630227
Pubmed	Extended genetic effects of ADH cluster genes on the risk of alcohol dependence: from GWAS to replication.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	23456092
Pubmed	Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	23468174
Pubmed	Tissue- and species-specific expression patterns of class I, III, and IV Adh and Aldh 1 mRNAs in rodent embryos.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	16047160
Pubmed	Organization of six functional mouse alcohol dehydrogenase genes on two overlapping bacterial artificial chromosomes.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	11784316
Pubmed	Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.	CYP2A6 CYP2A7 CYP2A13	2.21e-06	7	140	3	14630516
Pubmed	Androgen regulation of gene expression in primary epithelial cells of the mouse kidney.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	8119157
Pubmed	STOmicsDB: a comprehensive database for spatial transcriptomics data sharing, analysis and visualization.	ADH1A ADH1B ADH1C	2.21e-06	7	140	3	37953328
Pubmed	Isolation of genomic DNA fragments corresponding to genes modulated in vivo by a transcription factor.	ADH1A ADH1B ADH1C	3.52e-06	8	140	3	7937138
Pubmed	Association of ADH and ALDH genes with alcohol dependence in the Irish Affected Sib Pair Study of alcohol dependence (IASPSAD) sample.	ADH1A ADH1B ADH1C	3.52e-06	8	140	3	18331377
Pubmed	Biochemical and genetic characterization of esterase-27 (ES-27), the major plasma cholinesterase of the house mouse (Mus musculus).	ADH1A ADH1B ADH1C	3.52e-06	8	140	3	2040456
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYBBP1A MAP1A CORO1C MATR3 KIF1B DYRK1A RPS20 MDH2 STRIP1 DDX6 MAPK8IP3 MAGI2 VCAN C4A C4B PLCL1 NOS1 DDX39B HSPA8	5.03e-06	1431	140	19	37142655
Interaction	CYP2A7 interactions	CYP2A6 CYP2A7 CYP2A13	2.87e-07	3	134	3	int:CYP2A7
Cytoband	4q23	ADH1A ADH1B ADH1C	3.05e-05	20	140	3	4q23
Cytoband	Ensembl 112 genes in cytogenetic band chr4q23	ADH1A ADH1B ADH1C	2.00e-04	37	140	3	chr4q23
Cytoband	9q34.11	PHYHD1 ZDHHC12 HMCN2	5.82e-04	53	140	3	9q34.11
GeneFamily	Alcohol dehydrogenases	ADH1A ADH1B ADH1C	7.01e-06	8	92	3	397
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	WBP11 PTK2 ARFGEF3 SLC9A1 CSRNP3 PLCL1 HYDIN	3.84e-05	181	92	7	694
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2A13	7.42e-04	35	92	3	1001
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	GYPB C4A C4B	8.74e-04	37	92	3	454
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	9.01e-04	9	92	2	1234
GeneFamily	DEAD-box helicases	DDX6 DDX39A DDX39B	1.27e-03	42	92	3	499
GeneFamily	AT-rich interaction domain containing	ARID3A JARID2	2.58e-03	15	92	2	418
GeneFamily	Cadherin related	FAT1 PCDH15	3.31e-03	17	92	2	24
GeneFamily	Heat shock 70kDa proteins	HSPA12B HSPA8	3.31e-03	17	92	2	583
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS2 ADAMTS7	4.14e-03	19	92	2	50
GeneFamily	Protein phosphatase catalytic subunits\|STRIPAK complex	STRIP2 STRIP1	4.58e-03	20	92	2	1371
GeneFamily	PDZ domain containing	DVL2 PARD6G MAGI2 NOS1	7.57e-03	152	92	4	1220
Coexpression	MOHANKUMAR_HOXA1_TARGETS_UP	CORO1C CHD8 DDX6 MEST FAT1 ASF1B UNC5C CDC6 CDC25A RNF139 HSPA8 CRAMP1	1.89e-06	410	138	12	M4399
Coexpression	MCDOWELL_ACUTE_LUNG_INJURY_DN	ADH1A ADH1B ADH1C LLGL2 PEX16	8.01e-06	52	138	5	MM693
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	COL6A3 ADAMTS2 PLXDC1 CPED1 TMC3 ADH1C VCAN UNC5C ROBO2 CTRB1 MYRF	2.36e-05	373	133	11	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	COL6A3 ABCA1 TUT4 ADAMTS2 PLXDC1 CPED1 TMC3 NCAPG2 ADH1C FAT1 NCAPG VCAN UNC5C ROBO2 CTRB1 HSPA8	2.55e-05	768	133	16	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
ToppCell	IPF-Epithelial-Mesothelial\|IPF / Disease state, Lineage and Cell class	NPAS3 PKHD1L1 ADH1B MAGI2 MEST FAT1 C4A C4B MYRF MSLN	2.99e-10	180	140	10	1fa54bf4dba72866b2295639d991af639341bc08
ToppCell	IPF-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	NPAS3 PKHD1L1 ADH1B MAGI2 MEST FAT1 C4A C4B MSLN	6.93e-09	183	140	9	7df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZPBP PKHD1L1 ARFGEF3 HEPACAM IGSF9 C4B MYRF MSLN	7.88e-08	173	140	8	e05cddf5bf63cf419343ff229453327519765be8
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ZPBP PKHD1L1 ARFGEF3 HEPACAM IGSF9 C4B MYRF MSLN	7.88e-08	173	140	8	74ad5ed33821b8816c9c8e67c50ee4496ba18e2f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLH1 ADGRV1 PKHD1L1 ARFGEF3 FAT1 GUCY2F PCDH15 HYDIN	1.27e-07	184	140	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLH1 ADGRV1 PKHD1L1 ARFGEF3 FAT1 GUCY2F PCDH15 HYDIN	1.27e-07	184	140	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOLH1 ADGRV1 PKHD1L1 ARFGEF3 FAT1 GUCY2F PCDH15 HYDIN	1.27e-07	184	140	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL6A3 ADAMTS2 ADH1B MEST FHOD1 UNC5C PCDH15 ROBO2	1.43e-07	187	140	8	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	USP53 COL6A3 ADAMTS2 ADH1B VCAN UNC5C PCDH15 ROBO2	1.62e-07	190	140	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD19 LCK NCAPG2 NCAPG ASF1B CDC6 CDC25A DDX39A	1.62e-07	190	140	8	89095d3e023269d89c82e3a73550f869e3f34201
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD19 LCK NCAPG2 NCAPG ASF1B CDC6 CDC25A DDX39A	1.62e-07	190	140	8	b65383e256b04122500b742caeed0b807793851e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 ADAMTS2 ADH1B MAGI2 UNC5C PCDH15 ROBO2	1.83e-07	193	140	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 ADAMTS2 ADH1B MAGI2 UNC5C PCDH15 ROBO2	1.90e-07	194	140	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 ADAMTS2 ADH1B MAGI2 VCAN UNC5C PCDH15 ROBO2	1.90e-07	194	140	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 PLXDC1 CPED1 ADH1B GGT5 VCAN UNC5C	1.98e-07	195	140	8	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 ADAMTS2 ADH1B MAGI2 UNC5C PCDH15 ROBO2	2.05e-07	196	140	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	USP53 COL6A3 CSMD2 ADH1B MAGI2 VCAN UNC5C ROBO2	2.14e-07	197	140	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 ADAMTS2 ADH1B MAGI2 MEST VCAN UNC5C ROBO2	2.22e-07	198	140	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Biopsy_Other_PF-Mesenchymal-Mesothelial_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PKHD1L1 ADH1B MEST IGSF9 C4A C4B MYRF MSLN	2.22e-07	198	140	8	86736f01e61bf4961f060b24ee1f1f48340737dd
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.31e-07	199	140	8	2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.31e-07	199	140	8	9e87b64e16d595701c3beb07aa835afe3330bd10
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma\|TCGA-Endometrium / Sample_Type by Project: Shred V9	MTFP1 ZDHHC12 NCAPG LLGL2 ASF1B SLC25A10 CDC6 DDX39A	2.40e-07	200	140	8	e3ad8d592686a5d1e1fb8dd05c2f00eac4c5738f
ToppCell	TCGA-Endometrium-Primary_Tumor\|TCGA-Endometrium / Sample_Type by Project: Shred V9	MTFP1 ZDHHC12 NCAPG LLGL2 ASF1B SLC25A10 CDC6 DDX39A	2.40e-07	200	140	8	1cbb62df4ea1631fef8497e1702175605d0869e7
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 COL6A3 ADAMTS2 ADH1B VCAN UNC5C PCDH15 ROBO2	2.40e-07	200	140	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	TUT4 CSMD2 STRIP1 DDX6 JARID2 VCAN PCDH15	4.71e-07	149	140	7	768877bade04ca0321593b8470b5011ad8270431
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS20 ADGRV1 PKHD1L1 CSRNP3 PCDH15 C4B HYDIN	1.10e-06	169	140	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZPBP PKHD1L1 ARFGEF3 HEPACAM IGSF9 MYRF MSLN	1.29e-06	173	140	7	3d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZPBP PKHD1L1 ARFGEF3 HEPACAM IGSF9 MYRF MSLN	1.29e-06	173	140	7	3aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD19 NCAPG2 STRIP2 GGT5 NCAPG CDC6 CDC25A	1.50e-06	177	140	7	73ba0f0b4b33f10e9f036d6d9befa48a1258e682
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 NPAS3 CPED1 ADH1B HMCN2 VCAN PLCL1	1.50e-06	177	140	7	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CSMD2 NCAPG2 STRIP2 NCAPG ASF1B CDC6 CDC25A	1.61e-06	179	140	7	80112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS2 FOLH1 NPAS3 CPED1 ADH1B MAGI2 PCDH15	1.67e-06	180	140	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 ABCA1 GGT5 MAGI2 HMCN2 VCAN C4A	1.67e-06	180	140	7	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 MAP1A ADAMTS2 PLXDC1 ADH1B GGT5 VCAN	1.74e-06	181	140	7	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 MAP1A ADAMTS2 PLXDC1 ADH1B GGT5 VCAN	1.74e-06	181	140	7	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	COVID-cycling-\|COVID / Condition, Cell_class and T cell subcluster	PARD6G NCAPG2 NCAPG ASF1B GYPB CDC6 CDC25A	2.01e-06	185	140	7	eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	PKHD1L1 ADH1B MAGI2 FAT1 C4A C4B MSLN	2.01e-06	185	140	7	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 ADGRV1 ADH1A ARFGEF3 GIPR LLGL2 MS4A8	2.01e-06	185	140	7	eb78614c4acf8d2ce7874d7e51e16997b76127ef
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZPBP HSPA12B NCAPG2 NCAPG ASF1B CDC6 CDC25A	2.01e-06	185	140	7	a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef
ToppCell	COVID-cycling\|COVID / Condition, Cell_class and T cell subcluster	PARD6G NCAPG2 NCAPG ASF1B GYPB CDC6 CDC25A	2.01e-06	185	140	7	5112f966735fa48f0606adcfd5c0212ad5d3d77a
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	USP53 COL6A3 CPED1 MAGI2 VCAN UNC5C ROBO2	2.16e-06	187	140	7	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.16e-06	187	140	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL6A3 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.24e-06	188	140	7	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.24e-06	188	140	7	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	PKHD1L1 ADH1B MAGI2 FAT1 C4A C4B MSLN	2.32e-06	189	140	7	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.32e-06	189	140	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	PBMC-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	MATR3 NCAPG2 NCAPG ASF1B UTP20 CDC6 CDC25A	2.32e-06	189	140	7	946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.32e-06	189	140	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC3 PLXDC1 PARD6G HSPA12B GPR146 MS4A8 GIMAP6	2.40e-06	190	140	7	52213cd2a6a20772d4f49ba9ac0407abafa528db
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 PLXDC1 CPED1 GGT5 VCAN UNC5C	2.48e-06	191	140	7	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.48e-06	191	140	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ADAMTS2 PLXDC1 GGT5 FAT1 VCAN PLCL1	2.48e-06	191	140	7	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 PLXDC1 CPED1 GGT5 VCAN UNC5C	2.48e-06	191	140	7	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ADAMTS2 SLCO2B1 CPED1 ADH1A VCAN C4B	2.57e-06	192	140	7	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.57e-06	192	140	7	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ADAMTS2 SLCO2B1 CPED1 ADH1A VCAN C4B	2.57e-06	192	140	7	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.57e-06	192	140	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 ADAMTS2 SLCO2B1 CPED1 ADH1A VCAN C4B	2.57e-06	192	140	7	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.57e-06	192	140	7	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ADAMTS2 SLCO2B1 CPED1 ADH1A VCAN C4B	2.66e-06	193	140	7	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 ADAMTS2 HSPA12B JARID2 HMCN2 VCAN IL1RN	2.66e-06	193	140	7	b93f6af5999ad207fef5edc2bd900c7c6342f626
ToppCell	PND28-Mesenchymal-Mesenchymal_structural\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A ROBO2 C4B MSLN	2.66e-06	193	140	7	ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.66e-06	193	140	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 ADAMTS2 CPED1 ADH1B MAGI2 UNC5C PCDH15	2.66e-06	193	140	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL6A3 ADAMTS2 ADH1B MAGI2 UNC5C PCDH15 ROBO2	2.66e-06	193	140	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A ROBO2 C4B MSLN	2.66e-06	193	140	7	30481fb01c7acf85beae10213f038da86bed6777
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.75e-06	194	140	7	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A3 CPED1 ADH1C FHOD1 VCAN UNC5C ROBO2	2.75e-06	194	140	7	f2f7b9aad7588c8020a4850ff9333e1db8eafac7
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL6A3 ADH1B MAGI2 MEST VCAN UNC5C ROBO2	2.75e-06	194	140	7	8c37bedb23285735ff3828db3889897fada8c95d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 PLXDC1 CPED1 ADH1B GGT5 VCAN	2.75e-06	194	140	7	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 ADAMTS2 ADH1B MAGI2 FHOD1 UNC5C ROBO2	2.75e-06	194	140	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.75e-06	194	140	7	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 PLXDC1 CPED1 ADH1B GGT5 VCAN	2.75e-06	194	140	7	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.85e-06	195	140	7	cbe518b465b4ef32797ae6b608219207c08493df
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.85e-06	195	140	7	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A FHOD1 VCAN UNC5C	2.85e-06	195	140	7	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.85e-06	195	140	7	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	USP53 COL6A3 ADH1B MAGI2 UNC5C PCDH15 ROBO2	2.85e-06	195	140	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.85e-06	195	140	7	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A FHOD1 VCAN UNC5C	2.85e-06	195	140	7	8aa753934debffe5ae4b5eecb6b50c46d17cc3ec
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.85e-06	195	140	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL6A3 CPED1 MEST FAT1 VCAN UNC5C ROBO2	2.85e-06	195	140	7	c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.85e-06	195	140	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	PND03-Mesenchymal-Mesenchymal_structural\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.85e-06	195	140	7	136b06b0931a69b1241101f68c01c44c70365fd9
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.85e-06	195	140	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.85e-06	195	140	7	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 CPED1 ADH1A FHOD1 VCAN UNC5C ROBO2	2.85e-06	195	140	7	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A FHOD1 VCAN ROBO2	2.95e-06	196	140	7	97e26622d9582b092c18ff5b7e957818f99d9631
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.95e-06	196	140	7	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.95e-06	196	140	7	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 ADAMTS2 ADH1B MEST VCAN UNC5C ROBO2	2.95e-06	196	140	7	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.95e-06	196	140	7	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.95e-06	196	140	7	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A FHOD1 VCAN ROBO2	2.95e-06	196	140	7	f429f045ba45e24717963315832150b12a115bfa
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL6A3 RPS20 MAGI2 MEST VCAN UNC5C ROBO2	2.95e-06	196	140	7	22538376a95fe3afe8639a216a5497087aa94110
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 ADAMTS2 CPED1 ADH1A VCAN UNC5C ROBO2	2.95e-06	196	140	7	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	2.95e-06	196	140	7	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 COL6A3 ADAMTS2 ADH1B UNC5C PCDH15 ROBO2	2.95e-06	196	140	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Tracheal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HSPA12B PKHD1L1 GPR146 HDDC3 ZDHHC12 ASF1B BRF2	3.05e-06	197	140	7	e91572edbe48d40269ee2cf7c858764cff6985ac
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ADAMTS2 CPED1 ADH1B GGT5 VCAN UNC5C	3.05e-06	197	140	7	b349f8e96d61a4c296af64711e11fc44459a9413
Drug	2,2,2-trichloroethanol	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C UGT1A1 OXSM	1.28e-08	73	136	8	CID000008259
Drug	Endosulfan	CYP2A6 CYP2A7 CYP2A13 FOLH1 MDH2 PTK2 ADH1A ADH1B ADH1C UGT1A1 OR51D1 SLC9A1 CDC6 NOS1 HSPA8	7.77e-08	447	136	15	ctd:D004726
Drug	4-Iodopyrazole	ADH1A ADH1B ADH1C	2.08e-07	3	136	3	DB02721
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7 CYP2A13	2.08e-07	3	136	3	CID000068481
Drug	Fomepizole	ADH1A ADH1B ADH1C	8.30e-07	4	136	3	DB01213
Drug	N-nitrosomethylaniline	CYP2A6 CYP2A7 CYP2A13 OXSM	1.16e-06	14	136	4	CID000011957
Drug	willardine	FOLH1 ADH1A ADH1B ADH1C IL1RN	1.25e-06	32	136	5	CID000005123
Drug	phenoxyethanol	MDH2 ADH1A ADH1B ADH1C	2.10e-06	16	136	4	CID000031236
Drug	bz-Ala-OMe	CTRB2 OXSM CTRB1	4.12e-06	6	136	3	CID000023671
Drug	Ethanol	ADH1A ADH1B ADH1C	7.17e-06	7	136	3	DB00898
Drug	strontium malonate	ADAMTS2 ADH1A IL1RN	7.17e-06	7	136	3	CID010313457
Drug	LGD2226	ABCC3 ADAMTS2 MLYCD ADH1A IL1RN	7.95e-06	46	136	5	CID011560224
Drug	hydride	CYP2A6 CYP2A7 CYP2A13 PARP2 MDH2 ADH1A ADH1B ADH1C SLC9A1 GUCY1B2 GUCY2F VCAN SLC25A10 C4A OXSM NOS1 CRAMP1	1.04e-05	835	136	17	CID000000783
Drug	indium trihydride	CTRB2 OXSM CTRB1	1.14e-05	8	136	3	CID000024000
Drug	cholesteryl octanoate	CTRB2 LRP5 CTRB1	1.14e-05	8	136	3	CID000102015
Drug	N-heptylformamide	ADH1A ADH1B ADH1C	1.14e-05	8	136	3	CID000347402
Drug	chloral hydrate	CYP2A6 CYP2A7 CYP2A13 ADH1A ADH1B ADH1C MSLN	1.27e-05	129	136	7	CID000002707
Drug	rifampicin	ABCC3 CYP2A6 CYP2A7 CYP2A13 SLCO2B1 ADH1B ADH1C UGT1A1 OXSM HSPA8	1.59e-05	306	136	10	CID005381226
Drug	2-NA	ADH1A ADH1B ADH1C	1.71e-05	9	136	3	CID000074128
Drug	(3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol	ADH1A ADH1B ADH1C	1.71e-05	9	136	3	CID000440672
Drug	5-amino-2-nitrobenzoic acid	CTRB2 CTRB1 CRAMP1	1.71e-05	9	136	3	CID000083298
Drug	1H-pyrazol	CYP2A6 KIF1B CTRB2 ADH1A ADH1B ADH1C CTRB1	2.26e-05	141	136	7	CID000001048
Drug	TCPOBOP	ABCC3 CYP2A6 SLCO2B1 ADH1B ADH1C UGT1A1	2.29e-05	95	136	6	CID000005382
Drug	verbenone	CYP2A6 MDH2 ADH1A	2.43e-05	10	136	3	CID000029025
Drug	UDP-alpha-d-xylopyranose	ADH1A ADH1B ADH1C UGT1A1 VCAN	2.96e-05	60	136	5	CID000001165
Drug	lemongrass oil	CYP2A13 PARP2 ADH1C HSPA8	3.38e-05	31	136	4	ctd:C052901
Drug	nitroglycerin	ADH1A ADH1B ADH1C GUCY1B2 GUCY2F UTP20 NOS1 CRAMP1	3.43e-05	206	136	8	CID000004510
Drug	BOCPheONP	CTRB2 CTRB1	3.54e-05	2	136	2	CID000111308
Drug	MPM-06	CTRB2 CTRB1	3.54e-05	2	136	2	CID000161546
Drug	propargyl ether	CYP2A6 CYP2A13	3.54e-05	2	136	2	ctd:C531209
Drug	NSC-374899	CTRB2 CTRB1	3.54e-05	2	136	2	CID000435726
Drug	Hempa	CYP2A6 CYP2A13	3.54e-05	2	136	2	ctd:D006492
Drug	methylbenzenebutanoate	CTRB2 CTRB1	3.54e-05	2	136	2	CID000281254
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	3.54e-05	2	136	2	CID004418081
Drug	c189	CTRB2 CTRB1	3.54e-05	2	136	2	CID000248048
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	3.54e-05	2	136	2	CID000191369
Drug	nicotine imine	CYP2A6 CYP2A13	3.54e-05	2	136	2	ctd:C034629
Drug	alpha-nicotyrine	CYP2A6 CYP2A13	3.54e-05	2	136	2	ctd:C008615
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	3.54e-05	2	136	2	CID011820300
Drug	5-aminotetrazole	CTRB2 CTRB1	3.54e-05	2	136	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	3.54e-05	2	136	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	3.54e-05	2	136	2	CID000122753
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	3.54e-05	2	136	2	CID000191275
Drug	N-nitrosoguvacoline	CYP2A6 CYP2A13	3.54e-05	2	136	2	ctd:C036676
Drug	isobutyl sulfide	CTRB2 CTRB1	3.54e-05	2	136	2	CID000011607
Drug	walrycin A	CYP2A13 ADH1A ADH1B ADH1C	3.85e-05	32	136	4	ctd:C574123
Drug	allyl alcohol	MDH2 ADH1A ADH1B ADH1C NOS1	4.06e-05	64	136	5	CID000007858
Drug	AC1L1J0I	ADH1A ADH1B ADH1C	4.41e-05	12	136	3	CID000030201
Drug	AC1L2EXV	CTRB2 OXSM CTRB1	4.41e-05	12	136	3	CID000070823
Drug	hexa-2,4-dien-1-ol	ADH1A ADH1B ADH1C	4.41e-05	12	136	3	CID000008104
Drug	TCEO	CYP2A6 CYP2A7 CYP2A13 OXSM	4.91e-05	34	136	4	CID000028167
Drug	AC1L1CWO	CTRB2 ADH1B ADH1C CTRB1	5.52e-05	35	136	4	CID000002095
Drug	2-naphthaldehyde	ADH1A ADH1B ADH1C	5.71e-05	13	136	3	CID000006201
Drug	3-methylbutanal	ADH1A ADH1B ADH1C	5.71e-05	13	136	3	CID000011552
Drug	Uroguanylin	CTRB2 GUCY1B2 GUCY2F CTRB1	6.18e-05	36	136	4	CID005488765
Drug	AC1L3NGJ	CYP2A6 CYP2A7 CYP2A13 OXSM	6.18e-05	36	136	4	CID000092121
Drug	AC1L32JY	ADAMTS2 ADH1A LRP5 IL1RN	6.90e-05	37	136	4	CID000107685
Drug	naphthalenemethanol	ADH1A ADH1B ADH1C	7.23e-05	14	136	3	CID000020908
Drug	ivabradine	ADH1A VCAN PCDH15 IL1RN	8.52e-05	39	136	4	CID000132999
Drug	6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal	ADH1A ADH1B ADH1C	9.00e-05	15	136	3	CID000440673
Drug	ONO-3307	CTRB2 MDH2 CTRB1	9.00e-05	15	136	3	CID000127139
Drug	AHBs	CTRB2 LRP5 CTRB1	9.00e-05	15	136	3	CID000193414
Drug	N-benzylformamide	CYP2A6 ADH1B ADH1C GGT5 UGT1A1	9.29e-05	76	136	5	CID000080654
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	1.06e-04	3	136	2	CID000087784
Drug	photophor	CTRB2 CTRB1	1.06e-04	3	136	2	CID000014780
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	1.06e-04	3	136	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	1.06e-04	3	136	2	CID004309911
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	1.06e-04	3	136	2	CID000171547
Drug	AFMeq	CTRB2 CTRB1	1.06e-04	3	136	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	1.06e-04	3	136	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	1.06e-04	3	136	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	1.06e-04	3	136	2	CID000152933
Drug	c140	CTRB2 CTRB1	1.06e-04	3	136	2	CID002783250
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	1.06e-04	3	136	2	CID000127677
Drug	2-aminothiophenol	C4A C4B	1.06e-04	3	136	2	ctd:C005464
Drug	phenyl hippurate	CTRB2 CTRB1	1.06e-04	3	136	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	1.06e-04	3	136	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	1.06e-04	3	136	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	1.06e-04	3	136	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	1.06e-04	3	136	2	CID000328214
Drug	N6-acetyllysine	MLYCD AADAT	1.06e-04	3	136	2	CID000092832
Drug	C18 4	CTRB2 CTRB1	1.06e-04	3	136	2	CID000077248
Drug	taraxastane	CTRB2 CTRB1	1.06e-04	3	136	2	CID006429404
Drug	Phe-phe-ome	CTRB2 CTRB1	1.06e-04	3	136	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	1.06e-04	3	136	2	CID000065389
Drug	3-amino-2-pyridone	CTRB2 CTRB1	1.06e-04	3	136	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	1.06e-04	3	136	2	CID003035649
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	1.06e-04	3	136	2	CID000070396
Drug	Z-Phe-OMe	CTRB2 CTRB1	1.06e-04	3	136	2	CID003082435
Drug	3-methylcoumarin	CTRB2 CTRB1	1.06e-04	3	136	2	CID000017130
Drug	2-propyl methylphosphonochloridate	CTRB2 CTRB1	1.06e-04	3	136	2	CID000102124
Drug	FK-316	CTRB2 CTRB1	1.06e-04	3	136	2	CID000133688
Drug	AC1L19T8	CTRB2 CTRB1	1.06e-04	3	136	2	CID000000694
Drug	Marinostatin D	CTRB2 CTRB1	1.06e-04	3	136	2	CID000132206
Drug	1FD7	CTRB2 CTRB1	1.06e-04	3	136	2	CID000445579
Drug	Glt-leu-phe-nh-meq	CTRB2 CTRB1	1.06e-04	3	136	2	CID000194914
Drug	AC1L4Z4F	CTRB2 CTRB1	1.06e-04	3	136	2	CID000194913
Drug	Glt-Phe-NH-FMeq	CTRB2 CTRB1	1.06e-04	3	136	2	CID000194912
Drug	diacetyl trimer	CTRB2 CTRB1	1.06e-04	3	136	2	CID000193527
Drug	FK-448	CTRB2 CTRB1	1.06e-04	3	136	2	CID006917869
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	2.05e-05	2	134	2	OBA_2041192
Disease	Familial Colorectal Cancer Type X	RPS20 SEMA4A	6.12e-05	3	134	2	C3896578
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	6.12e-05	3	134	2	EFO_0801477
Disease	Mouth Neoplasms	PTK2 ADH1B ADH1C HSPA8	1.08e-04	54	134	4	C0026640
Disease	Malignant neoplasm of mouth	PTK2 ADH1B ADH1C HSPA8	1.08e-04	54	134	4	C0153381
Disease	sodium measurement	CYP2A6 ADH1B GIPR CSRNP3 PLCL1	1.10e-04	103	134	5	EFO_0009282
Disease	alcohol dependence measurement	ADH1A ADH1B ADH1C UNC5C	1.16e-04	55	134	4	EFO_0007835
Disease	ecosanoids measurement	ABCC3 ADH1A ADH1B MYRF	1.16e-04	55	134	4	EFO_0020044
Disease	C-reactive protein measurement	CYP2A6 CYP2A7 ABCA1 MAP1A FOLH1 ORC3 DYRK1A DDX6 MLYCD MAPK8IP3 ADH1B ADH1C GIPR PCDH15 IL1RN GIMAP6	1.20e-04	1206	134	16	EFO_0004458
Disease	Alcohol dependence	ADH1B ADH1C	2.03e-04	5	134	2	cv:C0001973
Disease	ALCOHOL DEPENDENCE	ADH1B ADH1C	2.03e-04	5	134	2	103780
Disease	methionine measurement	ADGRV1 PCDH15 PLCL1	2.21e-04	26	134	3	EFO_0009771
Disease	alkaline phosphatase measurement	CYP2A6 CYP2A7 MAP1A ADAMTS2 KLF3 DDX6 MLYCD ADH1B ADH1C CSRNP3 SLC12A9 PLCL1 IL1RN MYRF	2.21e-04	1015	134	14	EFO_0004533
Disease	renal cell carcinoma (is_implicated_in)	C4A C4B RNF139 IL1RN	2.80e-04	69	134	4	DOID:4450 (is_implicated_in)
Disease	CHARGE syndrome (implicated_via_orthology)	CHD8 CHD6	4.24e-04	7	134	2	DOID:0050834 (implicated_via_orthology)
Disease	myoclonic-atonic epilepsy (implicated_via_orthology)	SLC25A10 ROBO2	4.24e-04	7	134	2	DOID:0060475 (implicated_via_orthology)
Disease	Henoch-Schoenlein purpura (is_implicated_in)	MEFV IL1RN	5.63e-04	8	134	2	DOID:11123 (is_implicated_in)
Disease	alcohol use disorder measurement, longitudinal alcohol consumption measurement	ADH1A ADH1B ADH1C	6.36e-04	37	134	3	EFO_0007645, EFO_0009458
Disease	Liver Diseases, Parasitic	CYP2A6 ROBO2	7.22e-04	9	134	2	C0023897
Disease	Carcinoma, Small Cell	CYP2A6 UGT1A1	7.22e-04	9	134	2	C0262584
Disease	reticulocyte count	ABCA1 FOXK2 ARID3A CORO1C KLF3 ADH1B FAT1 GYPB LRP5 C4B DDX39A MYRF DDX39B	9.72e-04	1045	134	13	EFO_0007986
Disease	trypsin-2 measurement	CTRB2 CTRB1	1.10e-03	11	134	2	EFO_0008305
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7	1.31e-03	12	134	2	EFO_0007794
Disease	Neurobehavioral Manifestations	MAGI2 NOS1	1.31e-03	12	134	2	C0525041
Disease	IGF-1 measurement	MAP1A MLYCD MAPK8IP3 ADH1A ADH1B ADH1C SLC9A1 CRAMP1	1.79e-03	488	134	8	EFO_0004627
Disease	alcohol use disorder (is_implicated_in)	ADH1B ADH1C	2.36e-03	16	134	2	DOID:1574 (is_implicated_in)
Disease	phosphatidylcholine 38:6 measurement	ABCC3 MYRF	2.36e-03	16	134	2	EFO_0010388
Disease	white matter hyperintensity measurement	PARP2 PTK2 GGT5 AP5B1 VCAN CHD6	2.63e-03	302	134	6	EFO_0005665
Disease	systemic lupus erythematosus (is_implicated_in)	C4A C4B IL1RN	2.85e-03	62	134	3	DOID:9074 (is_implicated_in)
Disease	Disorder of eye	ADGRV1 VCAN PCDH15 LRP5 SEMA4A	2.88e-03	212	134	5	C0015397
Disease	Astigmatism	USP53 ADAMTS2 CHD6 PLCL1	2.89e-03	129	134	4	HP_0000483
Disease	emphysema pattern measurement	CYP2A6 GYPB	3.33e-03	19	134	2	EFO_0005850
Disease	renovascular hypertension (biomarker_via_orthology)	SLC9A1 NOS1	3.33e-03	19	134	2	DOID:1591 (biomarker_via_orthology)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	RPS20 SEMA4A	3.33e-03	19	134	2	C1333991
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7	3.33e-03	19	134	2	EFO_0007872
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	RPS20 SEMA4A	3.33e-03	19	134	2	C2936783
Disease	BMI-adjusted waist-hip ratio, physical activity measurement	ABCA1 CTRB2 CTRB1	3.86e-03	69	134	3	EFO_0007788, EFO_0008002
Disease	Left Ventricle Remodeling	SLC9A1 NOS1	4.06e-03	21	134	2	C0600520
Disease	Ventricular Remodeling	SLC9A1 NOS1	4.06e-03	21	134	2	C0600519
Disease	bone density, lean body mass	CPED1 CSRNP3	4.06e-03	21	134	2	EFO_0003923, EFO_0004995
Disease	sex interaction measurement, cerebral amyloid angiopathy	ADH1B ADH1C	4.06e-03	21	134	2	EFO_0006790, EFO_0008343
Disease	level of Phosphatidylcholine (18:1_20:4) in blood serum	ABCA1 MYRF	4.06e-03	21	134	2	OBA_2045104
Disease	metabolite measurement	ABCC3 CYP2A6 PHYHD1 ADH1A ADH1B UGT1A1 MAGI2 MYRF	4.15e-03	560	134	8	EFO_0004725
Disease	osteoporosis	ADGRV1 CSRNP3 LRP5	4.52e-03	73	134	3	EFO_0003882

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPAIHPVLSGLSRIV	CTRB2	21	Q6GPI1
VHVVIATPGRILDLI	DDX6	216	P26196
GPKPLIERVILHIQV	AADAT	276	Q8N5Z0
VGIHGPFLVIAPLST	CHD8	856	Q9HCK8
LITVPIGHGVRLNLS	CSMD2	2211	Q7Z408
RVPVLETTPVGKIDH	VCAN	1086	P13611
PRLLLFSPSVVHLGV	C4B	21	P0C0L5
GPVFTIHLGPRRVVV	CYP2A6	66	P11509
VIIKTLGIGFHLPVD	CPED1	886	A4D0V7
PLPVILGHEAAGIVE	ADH1A	61	P07327
PHIVVGTPGRILALA	DDX39B	166	Q13838
HVVVGTPGRILALVR	DDX39A	166	O00148
GNLVTPLPVILGHEA	ADH1B	56	P00325
PLPVILGHEAAGIVE	ADH1B	61	P00325
GNLVTPLPVILGHEA	ADH1C	56	P00326
PLPVILGHEAAGIVE	ADH1C	61	P00326
LVAIPLLVHSSRGPA	C1QL4	6	Q86Z23
VLDSVLVGPVPAGRH	ASF1A	56	Q9Y294
IVFTGITPGSIELPH	ABCA1	536	O95477
VGIAPSSRHILIGEP	ADGRV1	4151	Q8WXG9
IRLPHLEAVVIGRGP	APTX	31	Q7Z2E3
EPVVILEGHSKRVGI	CORO1C	121	Q9ULV4
LVPLLGVHEVVFAPV	GIPR	346	P48546
NKIVEVLGIPPAHIL	DYRK1A	371	Q13627
LVPAGIRLIPHTVLT	SLC25A10	256	Q9UBX3
VLRDIVHKPGPIVLT	DVL2	336	O14641
PLHGTITVLVIPVGD	ADAMTS2	811	O95450
PSIGNPIHITIVRLV	ADAMTS7	281	Q9UKP4
LLVVHEHRGTPVGLI	IMP4	136	Q96G21
SLGVILKVTHPPVVG	KCTD19	756	Q17RG1
PEGVLAGKTRVLVTH	ABCC3	796	O15438
VGILSHGLRIAPPEA	PARP2	436	Q9UGN5
HLETVIPAPGKRILV	KIN	331	O60870
TPEIPLGLQLHTVLV	CDRT15	61	Q96T59
HRRVVITGIGLVTPL	OXSM	41	Q9NWU1
AIHPTSGVIVLTGRL	FAT1	196	Q14517
PPVLTHLSLKSIIGI	NDRG3	121	Q9UGV2
LSRHGIRSPGILPVI	KLF3	131	P57682
TVPLPTISGHRELVL	MAP1A	511	P78559
TTPALVFGKPVRVHL	MATR3	456	P43243
STITVPHKIGRIIDG	MAGI2	946	Q86UL8
VISIPLTETVVLHRG	MAPK8IP3	1166	Q9UPT6
VVGILVLDGHSVPLP	LLGL2	776	Q6P1M3
QLDPGTLIVIRGHVP	LGALS8	26	O00214
VKVEPIPAIGHATLG	FOXK2	526	Q01167
HLTILVLPVFTTLPG	HMCN2	4116	Q8NDA2
PVPLIHRVAIVSEKG	KIF1B	986	O60333
VIGGHAGKTIIPLIS	MDH2	196	P40926
PALPGTHALVIGILV	AQP7P3	196	A6NL99
PALPGTHALVISILV	AQP7B	201	A0A075B734
PIGVARILTHEAGIT	HDDC3	36	Q8N4P3
IVVTPAFKGVSLHRP	KIAA1109	2151	Q2LD37
RGIAEAVGLPSIPVH	FOLH1	281	Q04609
PAHSSAIGPVIGIIL	LRP5	1381	O75197
PGEPLVVLHVALTGD	MLYCD	246	O95822
GLGTHAEVVPLPSVL	CSRNP3	396	Q8WYN3
VPLIGLSVVHRLGGP	OR51D1	266	Q8NGF3
LPGTVTEHPKLLRVL	FAM205A	751	Q6ZU69
LPGTVTEHPKLLRVL	FAM205BP	481	Q63HN1
TTALGLLTIPIIIHP	MTFP1	126	Q9UDX5
FGILLTEIVTHGRIP	LCK	426	P06239
PLTVAEVQKLLGPHV	MSLN	541	Q13421
IGDILHRAKTVPVPE	MEFV	531	O15553
LAGQPTVLTPLIHGL	AP5B1	476	Q2VPB7
RGLRVVVPHDVGLTI	HSPA12B	506	Q96MM6
VVPHDVGLTILKGAV	HSPA12B	511	Q96MM6
SLLPILVQHITGPVR	MYBBP1A	1011	Q9BQG0
RVTPHGLEKVPGIFI	PARD6G	181	Q9BYG4
GIASETHVVLILRGP	NOS1	86	P29475
TVKILVLHPGEIPRF	PCDH15	1021	Q96QU1
LVHRFTVPAPVVIIL	GYPB	51	P06028
ILDSVLVGPVPAGRH	ASF1B	56	Q9NVP2
LPIKVVGGPTVHICL	HYDIN	1676	Q4G0P3
GPVFTIHLGPRRVVV	CYP2A13	66	Q16696
RGIHGPFLIIAPLST	CHD6	506	Q8TD26
HPRAVLVPSSLRIGI	CERK	221	Q8TCT0
GPVFTIHLGPRRVVV	CYP2A7	66	P20853
AEVLHTVLAGRLLPP	CTU1	36	Q7Z7A3
LGGLDTIVKIPPHVL	ARFGEF3	31	Q5TH69
PVRIRIGLHSGPVVA	GUCY2F	976	P51841
GVAQRHIVLKPPTIV	COL6A3	421	P12111
LTPLPGVARVVHSKA	CRAMP1	406	Q96RY5
TIALLRGGHVVAPVL	GGT5	166	P36269
SEPLIPKRVGLIHIS	CDC6	421	Q99741
SKVDIPIRTGHPTVL	CCP110	321	O43303
LVTGRHPLPVITAAT	BRF2	216	Q9HAW0
VGVILFITDLSIPHP	MS4A8	151	Q9BY19
LEGVNITSPVRLIHG	HEPACAM	31	Q14CZ8
IDVVPIEPHALFLGI	IL1RN	71	P18510
GLTTLPPVHVIKAAL	FHOD1	706	Q9Y613
LILLGHTVIISRGKP	GPR146	251	Q96CH1
HPKARIIAEAGPIVI	DCTN6	36	O00399
VGSPEIVVLLHGFPT	MEST	66	Q5EB52
VPAIHPVLSGLSRIV	CTRB1	21	P17538
PVQRGALVLIHGEVV	PHYHD1	231	Q5SRE7
PRLLLFSPSVVHLGV	C4A	21	P0C0L4
PIVPTDGKRVIVVFH	CDC25A	416	P30304
IHDIVLVGGSTRIPK	HSPA8	331	P11142
SILRHLGAVPGVTIP	JARID2	901	Q92833
GIATSPIIIHRLLPH	ORC3	251	Q9UBD5
ITSTHPAVFLLVGIP	OR52K1	6	Q8NGK4
ITLTHPTAFLLVGIP	OR52K2	6	Q8NGK3
LADHVPGVGLVTRPL	PEX16	306	Q9Y5Y5
VPVIGLITELPLHIR	RNF139	161	Q8WU17
TGKTPVEPEVAIHRI	RPS20	6	P60866
SITIGGRLILPHVPA	UTP20	1291	O75691
VVGHISSPVVILPAV	TMC3	676	Q7Z5M5
TLVGLPRPIHESVKT	STRIP2	451	Q9ULQ0
IVLSAPGPHAVLLVT	GIMAP6	116	Q6P9H5
PHIVKLIGVITENPV	PTK2	481	Q05397
PVTGEPIQLRVGIHT	GUCY1B2	476	O75343
PIQLRVGIHTGPVLA	GUCY1B2	481	O75343
IPREHVKVPLTRVSG	SEMA4A	656	Q9H3S1
VVGLPRPIHESIKTL	STRIP1	456	Q5VSL9
ILPLVTGSGHVSVPF	SPCS3	156	P61009
VVLPLVHRVTGTLAA	NPAS3	801	Q8IXF0
GRLPVSLAGHPVVAA	ARID3A	411	Q99856
ESLILPGIISIHPVV	NCAPG	586	Q9BPX3
TPVHRGVLSTLIAGP	NCAPG2	1001	Q86XI2
VHPVLALSGRAPSIL	SHANK2-AS3	21	Q9BTD1
HLRTVGLKPETAPLI	USP53	866	Q70EK8
TKGILPGVSPLALHI	PLCL1	711	Q15111
PGVSPLALHIKIISG	PLCL1	716	Q15111
KLLLGHSEIRVPPVV	ZBTB45	61	Q96K62
SVKHSLPLLPGRTVL	TEP1	666	Q99973
VVGGVLVKRLHLGPV	SLCO2B1	426	O94956
LPRLGATIEHISVSP	WDR75	286	Q8IWA0
ESIPTIDGLRHVVVP	STAMBP	246	O95630
PVLTAVPGITRHLTK	ZC3H11A	596	O75152
TLIGGITGPIAKLIH	S100A16	81	Q96FQ6
DLGPTLLVHGVTPVT	SLC12A9	896	Q9BXP2
GPVVSHAGKILLIPV	UGT1A1	21	P22309
VVVALVGLLPVLRSH	SLC9A1	21	P19634
KIGFHVIPTISSIVP	SLC9A1	116	P19634
PRIVEHPSDVIVSKG	ROBO2	31	Q9HCK4
VITLHGHLRSPELPV	PKHD1L1	2261	Q86WI1
THATQLLVLGPPVIV	IGSF9	216	Q9P2J2
LVRVPSSVGHLVRLP	ZPBP	36	Q9BS86
GVLHVALPTVLTPLA	VWA5B2	146	Q8N398
GPTISVLVERPVKHL	WDR93	506	Q6P2C0
PVHLGTIVGIVLAVL	PLXDC1	421	Q8IUK5
IFHVLTPTRPLILSG	TBCCD1	396	Q9NVR7
PTRAVSILPLLGHGV	WBP11	176	Q9Y2W2
LLSPGVLVRTGHTVL	ZDHHC12	6	Q96GR4
HPGLRNILPITTAKV	TUT4	1041	Q5TAX3
VVLLPAGRPTASIVH	UBXN4	391	Q92575
SLGGHTLIVIPEVLL	PRR23C	91	Q6ZRP0
GHLIVPNSGVSLLIP	UNC5C	541	O95185
LPPEQVTKVTVGRLH	MYRF	466	Q9Y2G1